Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
86.2M
-
Number of holders
-
75
-
Total 13F shares, excl. options
-
23.7M
-
Shares change
-
+23.7M
-
Total reported value, excl. options
-
$249M
-
Value change
-
+$249M
-
Put/Call ratio
-
1.09
-
Number of buys
-
74
-
Price
-
$10.50
Significant Holders of Strata Critical Medical, Inc. - Common Stock, $0.0001 par value per share (SRTA) as of Q2 2021
91 filings reported holding SRTA - Strata Critical Medical, Inc. - Common Stock, $0.0001 par value per share as of Q2 2021.
Strata Critical Medical, Inc. - Common Stock, $0.0001 par value per share (SRTA) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23.7M shares
of 86.2M outstanding shares and own 27.51% of the company stock.
Largest 10 shareholders include HG Vora Capital Management, LLC (7.88M shares), ARK Investment Management LLC (3.93M shares), VANGUARD GROUP INC (2.41M shares), Nikko Asset Management Americas, Inc. (1.65M shares), Sumitomo Mitsui Trust Holdings, Inc. (1.65M shares), Raine Capital LLC (824K shares), BlackRock Inc. (757K shares), RiverPark Advisors, LLC (601K shares), GEODE CAPITAL MANAGEMENT, LLC (467K shares), and Deane Retirement Strategies, Inc. (323K shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.